Stay updated with breaking news from கட்டாய உரிமங்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Consider compulsory license for Covid-19 vaccine, laws for IP financing, piracy: Panel to govt indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Many presume that vaccines produced by the Serum Institute of India (SII) are “Indian vaccines” by default. Covishield, the mainstay of India’s vaccination programme used in more than 85% of India’s inoculations, is the result of a mutually beneficial international collaboration. At least half of the doses SII produces are paid for by other countries and global platforms, but manufactured in India. The deadly second wave created an unforeseen emergency and disrupted India’s role as a global supplier of vaccines. A recent analysis of company filings by the top four global vaccine manufacturers found that 90% all the vaccines produced in 2021 Q1 in the United States (US) and Europe were administered on populations within North America and Europe. Even in Q2, the situation is going to be the same. This brings to the front the importance of creating and expanding vaccine production capacity in the developing world. ....
FICCI supportive of âTRIPS waiverâ proposal to ramp up COVID-19 vaccines manufacturing FICCI supportive of âTRIPS waiverâ proposal to ramp up COVID-19 vaccines manufacturing 13 May 2021 | News The immediate focus has to be on connecting with the ârightâ global companies to facilitate âtechnology transferâ and voluntary licenses to Indian companies Source credit: Shutterstock FICCI is encouraged by the US support for the ‘TRIPS waiver’ proposal, first advocated by India and South Africa as one vital tool to address the concerns on availability of COVID-19 vaccines. We are confident, if accepted in the WTO and implemented, the temporary waiver would go a long way to enable scaling up of manufacturing and ensuring timely availability of affordable COVID-19 vaccines and essential medical products, says FICCI. ....
Focus on technology transfer, voluntary licenses to Indian companies to address vaccine shortage: FICCI SECTIONS Share Synopsis The immediate focus has to be on connecting with the right global companies to facilitate technology transfer and voluntary licenses to Indian companies that have the capacity and capability for mass-production of COVID vaccines, FICCI said. Reuters Representative Image The government should work on war-footing to alleviate the shortage of vaccines in the country which has put the lives of healthcare service providers, essential workers at risk, the Federation of Indian Chambers of Commerce and Industry said on Thursday. The immediate focus has to be on connecting with the right global companies to facilitate technology transfer and voluntary licenses to Indian companies that have the capacity and capability for mass-production of COVID vaccines, it said. ....